Table 1.
# | Compound | MDL μg kg−1 | Mean ± Std. Dev. μg kg−1 | Matrix-spike recovery % | Use |
---|---|---|---|---|---|
1 | 10-Hydroxy-amitriptyline | 0.4 | 14.4 ± 5.7 | 97.4 | Metabolite |
2 | Amitriptyline | 0.6 | 275.4 ± 92.8 | 78.8 | Antidepressant |
3 | Amlodipinea | 4.2 | ND (n = 3) | 47 | Ca2+ Channel blocker |
4 | Alprazolama | 0.7 | ND (n = 1) | 72.9 | Anxiolytic |
5 | Atenolola | 1.7 | ND (n = 1) | 94.9 | â blocker |
6 | Atorvastatina | 1.4 | ND (n = 4) | 79.7 | Antilipidemic |
7 | Benzoylecgoninea | 0.3 | ND (n = 2) | 92.1 | Metabolite |
8 | Benztropine | 0.5 | 2.9 ± 0.1 | 101 | Anticholinergic |
9 | Cocaine | 0.1 | 3.6 ± 3 | 97.6 | Illicit drug |
10 | DEET | 0.6 | 7.4 ± 2.8 | 112 | Insect repellant |
11 | Desmethyl-Diltiazem | 0.3 | 7.4 ± 6.1 | 357 | Metabolite |
12 | Furosemidea | 104 | ND (n = 2) | 92.6 | Diuretic |
13 | Glyburidea | 15.6 | ND (n = 2) | 104 | Antidiabetic |
14 | Hydrocodonea | 4.5 | ND (n = 4) | 83.8 | Narcotic analgesic |
15 | Metoprolol | 4.5 | 24.5 ± 10.1 | 93.4 | â blocker |
16 | Norfluoxetine | 2 | 42 ± 25.1 | 100 | Metabolite |
17 | Norverapamil | 0.3 | 458 ± 169.4 | 82.7 | Metabolite |
18 | Oxycodonea | 1.2 | ND (n = 3) | 108 | Narcotic analgesic |
19 | Paroxetine | 7.1 | 61.6 ± 21.7 | 105 | Anti-depressant |
20 | Promethazine | 0.6 | 22 ± 6.2 | 108 | Antihistamine |
21 | Propoxyphene | 1.2 | 50 ± 23.2 | 88.7 | Narcotic analgesic |
22 | Propranolol | 2.5 | 107.4 ± 36 | 91.2 | â-blocker |
23 | Sertraline | 0.5 | 458 ± 168.3 | 74 | Anti-depressant |
24 | Triamterene | 0.5 | 430.4 ± 139.9 | 81.2 | Diuretic |
25 | Valsartana | 9.2 | ND (n = 4) | 107 | Antihypertensive |
26 | Verapamil | 0.3 | 551.4 ± 226.2 | 92.2 | Ca2+ channel blocker |
More comprehensive information on each compound is available in SM.